LeMaitre Vascular (LMAT) financials
LeMaitre Vascular revenue and earnings by year
LeMaitre Vascular's revenue was $250 million in the fiscal year to December 31, 2025, up 13.5% from the year before. Net income was $57.7 million, 23.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 12.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 250 | 220 | 193 | 162 | 154 | 129 | 117 | 106 | 101 | 89 |
| Revenue growth | 13.5% | 13.6% | 19.7% | 4.7% | 19.4% | 10.4% | 11.0% | 4.7% | 13.1% | — |
| Gross profit | 179 | 151 | 127 | 105 | 101 | 85 | 80 | 74 | 71 | 63 |
| Gross margin | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% |
| Operating income | 68 | 52 | 37 | 27 | 36 | 29 | 21 | 28 | 21 | 16 |
| Operating margin | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.3% | 18.1% | 26.7% | 20.9% | 18.3% |
| Net income | 58 | 44 | 30 | 21 | 27 | 21 | 18 | 23 | 17 | 11 |
| Net margin | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% |
| Diluted EPS | $2.52 | $1.93 | $1.34 | $0.93 | $1.26 | $1.04 | $0.88 | $1.13 | $0.85 | $0.55 |
| Free cash flow | 74 | 37 | 29 | 23 | 30 | 34 | 10 | 16 | 16 | 14 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LMAT in Markets.
See also: LMAT valuation and P/E history · LMAT returns
No forecast, no recommendation. This page describes LeMaitre Vascular from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.